About Myra Vision
Myra Vision is a company based in Campbell (United States) founded in 2019. Myra Vision has raised $42 million across 2 funding rounds from investors including PA MedTech VC Fund, Cormorant and Capital Partnership. Myra Vision offers products and services including Calibreye TGT Surgical System. Myra Vision operates in a competitive market with competitors including Glaukos, Ivantis, Transcend Medical, InnFocus and Avisi Technologies, among others.
- Headquarter Campbell, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Myra Vision Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$42 M (USD)
in 2 rounds
-
Latest Funding Round
$25 M (USD), Series B
Jun 26, 2023
-
Investors
PA MedTech VC Fund
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Myra Vision
Myra Vision offers a comprehensive portfolio of products and services, including Calibreye TGT Surgical System.
Adjustable system for controlling intraocular pressure in glaucoma patients.
People of Myra Vision
Unlock access to complete
Funding Insights of Myra Vision
Myra Vision has successfully raised a total of $42M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Myra Vision
Myra Vision has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include PA MedTech VC Fund, Cormorant and Capital Partnership.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
An asset management and investment platform is operated by The Capital Partnership.
|
Locked | Locked | Locked | |
|
Medical technology innovation hub focused on device development in Silicon Valley.
|
Locked | Locked | Locked |
Investor details for Myra Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Myra Vision
Investment portfolio details for Myra Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Myra Vision
Detailed financials for Myra Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Myra Vision Comparisons
Peer comparison for Myra Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Myra Vision
Myra Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Ivantis, Transcend Medical, InnFocus and Avisi Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of implants to treat glaucoma
|
|
| Locked | Locked | Locked |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| Locked | Locked | Locked |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| Locked | Locked | Locked |
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
|
| Locked | Locked | Locked |
Nano-materials for glaucoma treatment implants are developed.
|
Detailed competitors of Myra Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Myra Vision
Complete news archive for Myra Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myra Vision
Myra Vision was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Myra Vision is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
Robert Chang is the current CEO of Myra Vision.
Myra Vision is a funded company, having raised a total of $42M across 2 funding rounds to date.
Myra Vision was founded in 2019 and is based in Campbell, United States. A medical device utilizing nanotechnology is developed for glaucoma management in the healthcare sector. Intraocular pressure is reduced by the device to address moderate to severe cases. Operations center on device innovation, with leadership provided by CEO Robert Chang. The domain myravision.com is maintained for company information.
Myra Vision's top competitors include Glaukos, Avisi Technologies and Ivantis.
Myra Vision offers Calibreye TGT Surgical System.
Myra Vision has 6 investors. Key investors include PA MedTech VC Fund, Cormorant, Capital Partnership, The Capital Partnership, and Shifamed.